CD36 and metabolic disease: In mouse models of metabolic disease, hepatic overexpression of CD36 increases liver triglyceride storage (Koonen et al. 2007), whereas the liver specific disruption of CD36 attenuates the development of fatty liver under HFD (Wilson et al. 2016).